Cardinal Health (CAH) FY2025 10-K Annual Report

Filed: Aug 12, 2025
Consumer Staples
Wholesale-Drugs, Proprietaries & Druggists' SundriesSEC EDGAR

Cardinal Health (CAH) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Aug 12, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

Cardinal Health FY2025 10-K Analysis

Risk Factors

  • Legal risk: Potential exposure from product liability and self-insurance accruals noted in loss contingencies, specifics not quantified but integral to financial estimates
  • Geopolitical exposure: GMPD segment manufacturing facilities in 12 countries including Germany, Japan, Malaysia, Mexico, and Costa Rica, subject to international operational risks
+3 more insights

Cardinal Health FY2025 Key Financial Metrics
XBRL

Revenue

$222.6B

-1.9% YoY

Net Income

$1.6B

+83.2% YoY

Gross Margin

3.7%

+40bp YoY

Operating Margin

1.0%

+47bp YoY

Net Margin

0.7%

+33bp YoY

ROE

-56.1%

-2961bp YoY

Total Assets

$53.1B

+17.7% YoY

EPS (Diluted)

$6.45

+87.0% YoY

Operating Cash Flow

$2.4B

-36.3% YoY

Source: XBRL data from Cardinal Health FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Cardinal Health

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.